Send feedback

NIPBL p.Pro464=

c.1392T>A · rs555179389 · VCV199182

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 5 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.0468%, eas)
Conditions
1
Cornelia de Lange syndrome 1

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 2.2GERP -1.3, phastCons 1
Overall
CADD9.371PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0468% East Asian · 21/44,866 alleles
Filtering AF 0.0313% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0263%
Overall 0.00136% 22/1,613,626 alleles · ultra-rare exomes 19/1,461,438 · genomes 3/152,188 · joint denominator
Ancestry group Frequency 1 in
East Asiangrpmax 0.0468% 2,136
Remaining individualsnot grpmax-eligible 0.0016% 62,498

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
NIPBL
Protein
p.Pro464=
Coding
c.1392T>A
MANE Select
NM_133433
dbSNP
rs555179389
Type
single nucleotide variant
Location
chr5:36976299 (GRCh38)
Gene constraint
LOEUF 0.057 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Full NIPBL gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nipbl-p-pro464 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown